← 產業報告目錄

Urinary Incontinence Devices Market by Product (Urinary Catheters (Indwelling Catheters, Intermittent Catheters), Artificial Urinary Sphincters), Incontinence Type (Stress), Patient Type (Male, Female), End User (Hospitals) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-03-12頁數 291報告編號 MD9331

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global Urinary incontinence devices market is projected to reach USD 7.97 billion by 2030 from USD 4.22 billion in 2024, at a CAGR of 11.2% during the forecast period. This is due to growing attention to personal hygiene and advancements in home healthcare solutions. Additionally, rapid urbanization and rising disposable income, consequently increasing the demand for the urinary incontinence devices. However, the potential side-effects & complications by using urinary incontinence devices such as catheters are the major restraint to the market. Additionally, the use of alternative treatment options to treat urinary icnotinence is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030. “The stress incontinence segment of urinary incontinence devices market by incontinence type to hold largest position forecast period.” Based on the incontinence type, the urinary incontinence devices market is divided into stress incontinence, urge incontinence, mixed incontinence, overflow incontinence, and functional incontinence. Among these, in 2023 stress incontinence segment account for the largest market share of XX% in urinary incontinence devices market. Factors driving the growth of stress incontinence segment include rising aging population, which increases the prevalence of pelvic floor dysfunction, particularly among postmenopausal women. The growing prevalence of stress incontinence is driving demand for urinary incontinence devices, including urinary catheters, vaginal & urethral slings, artificial urinary sphincters, electrical stimulation devices are among the others. According to National Center for Biotechnology Information (NCBI), stress urinary incontinence (SUI) is the most reported type, accounting for 37.5% of cases. This significant prevalence highlights the growing demand for urinary incontinence devices. “The female patients segment accounts for the largest market share in urinary incontinence devices market.” Based on patient type, the urinary incontinence devices market is segmented into male patients and female patients. The female patients segment accounts for the largest market share in urinary incontinence devices market. Women are more prone to incontinence than men, owing to factors such as pregnancy, childbirth, and menopause. During each of these events, women can face bladder control issues. Pregnancy can be a short-term cause of incontinence and bladder control issues. Some women experience incontinence after delivery because of the strain childbirth takes on the pelvic floor muscles. During menopause, the decreasing level of estrogen affects bladder control. However, the prevalence of incontinence is known to increase with age, with up to 75% of women above 65 years reporting an episode of incontinence such as urine leakage, further strengthens market demand for urinary incontinence devices among this segment. “North America accounted for the second largest share of the urinary incontinence devices market by region.” The global urinary incontinence devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Urinary incontinence devices market in North America is the second-largest regional market. This is due to the growing geriatric population along with rising prevalence of urinary incontinence as well as rapid advancement of healthcare infrastructure. The industry has long been established in the area, with high early-stage support and adoption by clinicians for research and emerging technologies. It is characterized by significant market penetration of urinary incontinence devices among key end users. However, the population of North America was approximately 375 million in 2023, with 66.8 million people aged 65 and above, a demographic that is particularly at risk of urinary incontinence. Such factors create a favorable environment for the growth of the urinary incontinence devices market in this region. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30% • By Designation: C-level–27%, Director-level–18% and Others–55% • By Region: Europe–35%, North America–30%, Asia Pacific–22%, Latin America- 10%, and Middle east and Africa – 3% Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the urinary incontinence devices market are Coloplast Corp (Denmark), B. Braun SE (Germany), Johnson & Johnson Services, Inc. (US), Convatec Inc. (UK), Boston Scientific Corporation (US), Hollister Incorporated (US), Becton, Dickinson and Company (BD) (US), Cook Group (US), Cardinal Health (US), Laborie (US), Medtronic (Ireland), and Teleflex Incorporated (US). Research Coverage This report studies the urinary incontinence devices market based on product, incontinence type, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence. This report provides insights on the following pointers: • Analysis of Key divers (Rising prevalence of urinary incontinence, Expanding geriatric population, Growing attention to personal hygiene, and Advancements in home healthcare solutions), restraints (Social stigma associate with incontinence care products, Environmental concerns related to disposal of urinary incontinence products, and Potential side-effects & complications), Challenge (Use of alternative treatment options), opportunity (Technological advancements in urinary incontinence devices and Rapid urbanization and rising disposable income) • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the urinary incontinence devices market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches & product approvals in the urinary incontinence devices market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the urinary incontinence devices market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 MARKETS COVERED & REGIONS CONSIDERED 28 1.3.2 INCLUSIONS & EXCLUSIONS 29 1.3.3 YEARS CONSIDERED 29 1.3.4 CURRENCY CONSIDERED 29 1.4 STAKEHOLDERS 30 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY DATA 32 2.1.1.1 Key sources for secondary data 32 2.1.1.2 Key data from secondary sources 33 2.1.2 PRIMARY DATA 33 2.1.2.1 Key primary sources 34 2.1.2.2 Key data from primary sources 35 2.1.2.3 Key industry insights 36 2.1.2.4 Breakdown of primary interviews 36 2.2 MARKET SIZE ESTIMATION 37 2.2.1 BOTTOM-UP APPROACH 37 2.2.1.1 Company revenue estimation approach 38 2.2.1.1.1 Presentations of companies and primary interviews 38 2.2.1.1.2 Primary interviews 39 2.2.1.1.3 US-based approach 39 2.2.2 TOP-DOWN APPROACH 41 2.3 DATA TRIANGULATION 42 2.4 MARKET SHARE ESTIMATION 43 2.5 ASSUMPTIONS 43 2.5.1 STUDY ASSUMPTIONS 43 2.5.2 GROWTH RATE ASSUMPTIONS 43 2.6 RESEARCH LIMITATIONS 44 2.6.1 METHODOLOGY-RELATED LIMITATIONS 44 2.6.2 SCOPE-RELATED LIMITATIONS 44 2.7 RISK ASSESSMENT 44 3 EXECUTIVE SUMMARY 45 4 PREMIUM INSIGHTS 49 4.1 URINARY INCONTINENCE DEVICES MARKET OVERVIEW 49 4.2 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT & COUNTRY (2023) 50 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES 51 4.4 REGIONAL MIX: URINARY INCONTINENCE DEVICES MARKET, 2024 VS. 2030 52 4.5 URINARY INCONTINENCE DEVICES MARKET: DEVELOPED VS. EMERGING MARKETS 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 5.2.1 DRIVERS 55 5.2.1.1 Rising prevalence of urinary incontinence 55 5.2.1.2 Expanding geriatric population 56 5.2.1.3 Growing attention to personal hygiene 56 5.2.1.4 Advancements in home healthcare solutions 57 5.2.2 RESTRAINTS 58 5.2.2.1 Social stigma associated with incontinence care products 58 5.2.2.2 Environmental concerns related to disposal of urinary incontinence products 58 5.2.2.3 Potential side-effects & complications 59 5.2.3 OPPORTUNITIES 59 5.2.3.1 Technological advancements in urinary incontinence devices 59 5.2.3.2 Rapid urbanization and rising disposable income 60 5.2.4 CHALLENGES 61 5.2.4.1 Use of alternative treatment options 61 5.3 PRICING ANALYSIS 61 5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 61 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 62 5.4 VALUE CHAIN ANALYSIS 63 5.5 SUPPLY CHAIN ANALYSIS 64 5.6 ECOSYSTEM ANALYSIS 65 5.7 PORTER’S FIVE FORCES ANALYSIS 67 5.7.1 THREAT OF NEW ENTRANTS 68 5.7.2 THREAT OF SUBSTITUTES 69 5.7.3 BARGAINING POWER OF BUYERS 69 5.7.4 BARGAINING POWER OF SUPPLIERS 69 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69 5.8 KEY STAKEHOLDERS & BUYING CRITERIA 69 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 70 5.8.2 KEY BUYING CRITERIA 70   5.9 REGULATORY LANDSCAPE 71 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 5.9.2 REGULATORY FRAMEWORK 73 5.9.2.1 North America 73 5.9.2.1.1 US 73 5.9.2.1.2 Canada 74 5.9.2.2 Europe 75 5.9.2.3 Asia Pacific 75 5.9.2.3.1 China 75 5.9.2.3.2 Japan 75 5.9.2.3.3 India 75 5.9.2.4 Latin America 75 5.9.2.4.1 Brazil 76 5.9.2.4.2 Mexico 76 5.9.2.5 Middle East 76 5.9.2.6 Africa 76 5.10 TRADE ANALYSIS 77 5.10.1 IMPORT DATA FOR HS CODE 901839 77 5.10.2 EXPORT DATA FOR HS CODE 901839 77 5.11 PATENT ANALYSIS 78 5.11.1 LIST OF MAJOR PATENTS 79 5.12 KEY CONFERENCES & EVENTS, 2025–2026 79 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.14 TECHNOLOGY ANALYSIS 82 5.14.1 KEY TECHNOLOGIES 82 5.14.1.1 Surgical & implantable devices 82 5.14.2 COMPLEMENTARY TECHNOLOGIES 83 5.14.2.1 Electrical stimulation devices 83 5.15 INVESTMENT & FUNDING SCENARIO 83 5.16 IMPACT OF AI/GEN AI ON URINARY INCONTINENCE DEVICES MARKET 84 5.16.1 AI USE CASES 84 6 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT 85 6.1 INTRODUCTION 86 6.2 URINARY CATHETERS 86 6.2.1 INTERMITTENT CATHETERS 89 6.2.1.1 Reduced risk of infections to boost market 89 6.2.2 INDWELLING CATHETERS 92 6.2.2.1 Rising usage by critically ill patients to drive demand 92 6.2.3 EXTERNAL CATHETERS 94 6.2.3.1 Ease of use to boost market growth 94 6.3 VAGINAL & URETHRAL SLINGS 97 6.3.1 RISING PREVALENCE OF STRESS INCONTINENCE TO DRIVE GROWTH 97 6.4 ELECTRICAL STIMULATION DEVICES 99 6.4.1 GROWING PREFERENCE FOR ELECTRICAL STIMULATION DEVICES FOR TREATMENT OF OAB TO DRIVE GROWTH 99 6.5 ARTIFICIAL URINARY SPHINCTERS 102 6.5.1 REDUCED RISK OF INFECTIONS ASSOCIATED WITH ARTIFICIAL URINARY SPHINCTERS TO DRIVE ADOPTION 102 6.6 OTHER URINARY INCONTINENCE DEVICES 105 7 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE 109 7.1 INTRODUCTION 110 7.2 STRESS INCONTINENCE 110 7.2.1 GROWING PREVALENCE OF STRESS INCONTINENCE TO DRIVE MARKET GROWTH 110 7.3 URGE INCONTINENCE 114 7.3.1 CONTINUOUS INNOVATIONS TO SUSTAIN MARKET GROWTH 114 7.4 MIXED INCONTINENCE 117 7.4.1 GROWING AWARENESS AMONG BOTH PATIENTS AND HEALTHCARE PROVIDERS TO BOOST MARKET GROWTH 117 7.5 OVERFLOW INCONTINENCE 120 7.5.1 AGING POPULATION AND ASSOCIATED UROLOGICAL CONDITIONS TO DRIVE MARKET DEMAND 120 7.6 FUNCTIONAL INCONTINENCE 123 7.6.1 MOBILITY DISORDERS TO SUSTAIN MARKET GROWTH 123 8 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE 127 8.1 INTRODUCTION 128 8.2 FEMALE PATIENTS 128 8.2.1 HIGHER RATE OF URINARY INCONTINENCE IN FEMALES TO DRIVE MARKET 128 8.3 MALE PATIENTS 131 8.3.1 RISING PREVALENCE OF BPH TO PROPEL MARKET GROWTH 131 9 URINARY INCONTINENCE DEVICES MARKET, BY END USER 135 9.1 INTRODUCTION 136 9.2 HOSPITALS 136 9.2.1 LARGE VOLUME OF SURGICAL PROCEDURES TO DRIVE GROWTH 136 9.3 PHYSICIANS’ OFFICES 139 9.3.1 EXPERTISE OF PROFESSIONALS IN TREATMENT OF URINARY INCONTINENCE TO PROPEL GROWTH 139 9.4 OTHER END USERS 141   10 URINARY INCONTINENCE DEVICES MARKET, BY REGION 145 10.1 INTRODUCTION 146 10.2 NORTH AMERICA 146 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 147 10.2.2 US 150 10.2.2.1 Favorable healthcare initiatives for prevention of UI to drive market 150 10.2.3 CANADA 153 10.2.3.1 Increasing geriatric population to drive market growth 153 10.3 EUROPE 156 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158 10.3.2 GERMANY 161 10.3.2.1 Rising healthcare expenditure to propel market 161 10.3.3 UK 164 10.3.3.1 Rising prevalence of chronic diseases to support market growth 164 10.3.4 FRANCE 167 10.3.4.1 Large target population to boost demand 167 10.3.5 ITALY 170 10.3.5.1 Rising geriatric population and subsequent rise in UI to drive market 170 10.3.6 SPAIN 173 10.3.6.1 Uptake of advanced technologies for UI treatment to support market growth 173 10.3.7 REST OF EUROPE 176 10.4 ASIA PACIFIC 179 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 180 10.4.2 CHINA 184 10.4.2.1 Growing focus on preventive care due to large target patient pool to boost demand 184 10.4.3 JAPAN 187 10.4.3.1 Presence of established healthcare system and favorable reimbursements to drive market 187 10.4.4 INDIA 190 10.4.4.1 Rising cases of urinary incontinence and increasing healthcare investments to propel market 190 10.4.5 REST OF ASIA PACIFIC 193 10.5 LATIN AMERICA 196 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 197 10.5.2 BRAZIL 200 10.5.2.1 Favorable reimbursement scenario for medical device manufacturers to drive market 200 10.5.3 MEXICO 203 10.5.3.1 Rising demand for advanced UI products to drive market 203 10.5.4 REST OF LATIN AMERICA 206 10.6 MIDDLE EAST & AFRICA 209 10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 209 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 210 11 COMPETITIVE LANDSCAPE 214 11.1 INTRODUCTION 214 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 214 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET 214 11.3 REVENUE ANALYSIS, 2019–2023 216 11.4 MARKET SHARE ANALYSIS, 2023 217 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 219 11.5.1 STARS 219 11.5.2 EMERGING LEADERS 219 11.5.3 PERVASIVE PLAYERS 219 11.5.4 PARTICIPANTS 219 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 221 11.5.5.1 Company footprint 221 11.5.5.2 Region footprint 222 11.5.5.3 Product footprint 223 11.5.5.4 Patient type footprint 224 11.5.5.5 End-user footprint 225 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 225 11.6.1 PROGRESSIVE COMPANIES 225 11.6.2 RESPONSIVE COMPANIES 225 11.6.3 DYNAMIC COMPANIES 226 11.6.4 STARTING BLOCKS 226 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 227 11.6.5.1 Detailed list of key startup/SME players 227 11.6.5.2 Competitive benchmarking of key emerging players/startups 227 11.7 COMPANY VALUATION & FINANCIAL METRICS 228 11.8 BRAND/PRODUCT COMPARISON 229 11.9 COMPETITIVE SCENARIO 230 11.9.1 PRODUCT LAUNCHES & APPROVALS 230 11.9.2 DEALS 231 11.9.3 EXPANSIONS 232 11.9.4 OTHER DEVELOPMENTS 232 12 COMPANY PROFILES 233 12.1 KEY PLAYERS 233 12.1.1 COLOPLAST CORP. 233 12.1.1.1 Business overview 233 12.1.1.2 Products offered 235 12.1.1.3 Recent developments 236 12.1.1.3.1 Product launches 236 12.1.1.3.2 Expansions 236 12.1.1.4 MnM view 237 12.1.1.4.1 Key strengths 237 12.1.1.4.2 Strategic choices 237 12.1.1.4.3 Weaknesses & competitive threats 237 12.1.2 B. BRAUN SE 238 12.1.2.1 Business overview 238 12.1.2.2 Products offered 240 12.1.2.3 MnM view 241 12.1.2.3.1 Key strengths 241 12.1.2.3.2 Strategic choices 241 12.1.2.3.3 Weaknesses & competitive threats 241 12.1.3 JOHNSON & JOHNSON SERVICES, INC. 242 12.1.3.1 Business overview 242 12.1.3.2 Products offered 243 12.1.3.3 MnM view 244 12.1.3.3.1 Key strengths 244 12.1.3.3.2 Strategic choices 244 12.1.3.3.3 Weaknesses & competitive threats 244 12.1.4 CONVATEC INC. 245 12.1.4.1 Business overview 245 12.1.4.2 Products offered 247 12.1.4.3 Recent developments 247 12.1.4.3.1 Product launches 247 12.1.4.3.2 Deals 248 12.1.4.4 MnM view 248 12.1.4.4.1 Key strengths 248 12.1.4.4.2 Strategic choices 248 12.1.4.4.3 Weaknesses & competitive threats 248 12.1.5 BOSTON SCIENTIFIC CORPORATION 249 12.1.5.1 Business overview 249 12.1.5.2 Products offered 251 12.1.5.3 Recent developments 251 12.1.5.3.1 Deals 251 12.1.5.4 MnM view 252 12.1.5.4.1 Key strengths 252 12.1.5.4.2 Strategic choices 252 12.1.5.4.3 Weaknesses & competitive threats 252   12.1.6 MEDTRONIC 253 12.1.6.1 Business overview 253 12.1.6.2 Products offered 254 12.1.6.3 Recent developments 255 12.1.6.3.1 Product approvals 255 12.1.7 TELEFLEX INCORPORATED 256 12.1.7.1 Business overview 256 12.1.7.2 Products offered 258 12.1.8 BECTON, DICKINSON AND COMPANY (BD) 259 12.1.8.1 Business overview 259 12.1.8.2 Products offered 260 12.1.9 CARDINAL HEALTH 261 12.1.9.1 Business overview 261 12.1.9.2 Products offered 263 12.1.10 HOLLISTER INCORPORATED 264 12.1.10.1 Business overview 264 12.1.10.2 Products offered 265 12.1.10.3 Recent developments 265 12.1.10.3.1 Product launches 265 12.1.11 COOK GROUP 266 12.1.11.1 Business overview 266 12.1.11.2 Products offered 266 12.1.12 LABORIE 267 12.1.12.1 Business overview 267 12.1.12.2 Products offered 267 12.1.12.3 Recent developments 268 12.1.12.3.1 Other developments 268 12.2 OTHER PLAYERS 269 12.2.1 WELLSPECT HEALTHCARE 269 12.2.2 CALDERA MEDICAL 270 12.2.3 DYNAREX CORPORATION 271 12.2.4 ADVACARE PHARMA 272 12.2.5 MRK HEALTHCARE PVT. LTD. 273 12.2.6 ADVIN HEALTH CARE 274 12.2.7 CLINIMED LIMITED 275 12.2.8 STERIMED GROUP 276 12.2.9 KIMBERLY-CLARK CORPORATION (KCWW) 277 12.2.10 INCONTROL MEDICAL 278 12.2.11 ZEPHYR SURGICAL IMPLANTS 279 12.2.12 FLEXICARE (GROUP) LIMITED 280 12.2.13 STRYKER 281 13 APPENDIX 282 13.1 DISCUSSION GUIDE 282 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287 13.3 CUSTOMIZATION OPTIONS 289 13.4 RELATED REPORTS 289 13.5 AUTHOR DETAILS 290
圖表清單 List of Tables & Figures
TABLE 1 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 35 TABLE 2 URINARY INCONTINENCE DEVICES MARKET: STUDY ASSUMPTIONS 43 TABLE 3 URINARY INCONTINENCE DEVICES MARKET: RISK ASSESSMENT 44 TABLE 4 PREVALENCE OF URINARY INCONTINENCE AMONG OLDER WOMEN, BY REGION 55 TABLE 5 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES, BY KEY PLAYER, 2022–2024 62 TABLE 6 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES, BY REGION, 2021–2023 62 TABLE 7 URINARY INCONTINENCE DEVICES MARKET: ROLE IN ECOSYSTEM 66 TABLE 8 URINARY INCONTINENCE DEVICES MARKET: PORTER’S FIVE FORCES 67 TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 70 TABLE 10 KEY BUYING CRITERIA FOR MAJOR END USERS 71 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 16 US FDA: MEDICAL DEVICE CLASSIFICATION 74 TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 74 TABLE 18 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD THOUSAND) 77 TABLE 19 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD THOUSAND) 77 TABLE 20 URINARY INCONTINENCE DEVICES MARKET: LIST OF MAJOR PATENTS 79 TABLE 21 URINARY INCONTINENCE DEVICES MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 80 TABLE 22 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 86 TABLE 23 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY REGION, 2022–2030 (USD MILLION) 87 TABLE 24 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 87 TABLE 25 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 88 TABLE 26 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 88 TABLE 27 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 89 TABLE 28 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 89 TABLE 29 URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY REGION, 2022–2030 (USD MILLION) 90 TABLE 30 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 90 TABLE 31 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 91 TABLE 32 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 91 TABLE 33 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 92 TABLE 34 URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY REGION, 2022–2030 (USD MILLION) 92 TABLE 35 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 93 TABLE 36 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 93 TABLE 37 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 94 TABLE 38 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 94 TABLE 39 URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY REGION, 2022–2030 (USD MILLION) 95 TABLE 40 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 95 TABLE 41 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 96 TABLE 42 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 96 TABLE 43 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 97 TABLE 44 URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY REGION, 2022–2030 (USD MILLION) 97 TABLE 45 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 46 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 47 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 99 TABLE 48 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 99 TABLE 49 URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2022–2030 (USD MILLION) 100 TABLE 50 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 51 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 101 TABLE 52 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 101 TABLE 53 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 102 TABLE 54 URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2022–2030 (USD MILLION) 103 TABLE 55 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 103 TABLE 56 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 57 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 58 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 105 TABLE 59 OTHER URINARY INCONTINENCE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 106 TABLE 60 NORTH AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 106 TABLE 61 EUROPE: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 62 ASIA PACIFIC: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 63 LATIN AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 108 TABLE 64 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 110 TABLE 65 KEY PRODUCTS FOR TREATMENT OF STRESS INCONTINENCE 111 TABLE 66 URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY REGION, 2022–2030 (USD MILLION) 112 TABLE 67 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 112 TABLE 68 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 69 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 70 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 71 URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY REGION, 2022–2030 (USD MILLION) 115 TABLE 72 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 115 TABLE 73 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 74 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 75 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 76 URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 77 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 118 TABLE 78 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 79 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 80 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 120 TABLE 81 URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY REGION, 2022–2030 (USD MILLION) 121 TABLE 82 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 121 TABLE 83 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 122 TABLE 84 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 122 TABLE 85 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 123 TABLE 86 URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY REGION, 2022–2030 (USD MILLION) 124 TABLE 87 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 124 TABLE 88 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 89 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 90 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 126 TABLE 91 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 128 TABLE 92 URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 129 TABLE 93 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 129 TABLE 94 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 130 TABLE 95 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 130 TABLE 96 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 131 TABLE 97 URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 132 TABLE 98 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 132 TABLE 99 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 133 TABLE 100 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 133 TABLE 101 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 134 TABLE 102 URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 136 TABLE 103 URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 137 TABLE 104 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 137 TABLE 105 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 138 TABLE 106 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 138 TABLE 107 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 108 URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY REGION, 2022–2030 (USD MILLION) 139 TABLE 109 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 140 TABLE 110 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 140 TABLE 111 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 141 TABLE 112 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 141 TABLE 113 URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 142 TABLE 114 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 142 TABLE 115 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 143 TABLE 116 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 143 TABLE 117 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 144 TABLE 118 URINARY INCONTINENCE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 146 TABLE 119 NORTH AMERICA: MACROECONOMIC INDICATORS 147 TABLE 120 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 147 TABLE 121 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 148 TABLE 122 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 148 TABLE 123 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 149 TABLE 124 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 149 TABLE 125 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 149 TABLE 126 US: NUMBER OF INDWELLING/FOLEY CATHETERS SOLD IN US (MILLION) 150 TABLE 127 US: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 151 TABLE 128 US: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 151 TABLE 129 US: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 152 TABLE 130 US: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 152 TABLE 131 US: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 153 TABLE 132 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 154 TABLE 133 CANADA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 154 TABLE 134 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 155 TABLE 135 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 155 TABLE 136 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 156 TABLE 137 EUROPE: MACROECONOMIC INDICATORS 158 TABLE 138 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 158 TABLE 139 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 159 TABLE 140 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 159 TABLE 141 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 160 TABLE 142 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 160 TABLE 143 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 161 TABLE 144 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 162 TABLE 145 GERMANY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 162 TABLE 146 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 163 TABLE 147 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 163 TABLE 148 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 164 TABLE 149 UK: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 165 TABLE 150 UK: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 165 TABLE 151 UK: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 166 TABLE 152 UK: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 166 TABLE 153 UK: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 167 TABLE 154 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 168 TABLE 155 FRANCE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 168 TABLE 156 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 169 TABLE 157 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 169 TABLE 158 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 170 TABLE 159 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 171 TABLE 160 ITALY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 171 TABLE 161 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 172 TABLE 162 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 172 TABLE 163 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 173 TABLE 164 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 174 TABLE 165 SPAIN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 174 TABLE 166 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 175 TABLE 167 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 175 TABLE 168 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 176 TABLE 169 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 177 TABLE 170 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 177 TABLE 171 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 178 TABLE 172 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 178 TABLE 173 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 179 TABLE 174 ASIA PACIFIC: MACROECONOMIC INDICATORS 180 TABLE 175 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 182 TABLE 176 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 182 TABLE 177 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 183 TABLE 178 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 183 TABLE 179 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 184 TABLE 180 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 184 TABLE 181 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 185 TABLE 182 CHINA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 186 TABLE 183 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 186 TABLE 184 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 187 TABLE 185 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 187 TABLE 186 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 188 TABLE 187 JAPAN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 189 TABLE 188 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 189 TABLE 189 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 190 TABLE 190 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 190 TABLE 191 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 191 TABLE 192 INDIA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 192 TABLE 193 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 192 TABLE 194 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 193 TABLE 195 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 193 TABLE 196 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 194 TABLE 197 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 195 TABLE 198 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 195 TABLE 199 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 196 TABLE 200 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 196 TABLE 201 LATIN AMERICA: MACROECONOMIC INDICATORS 197 TABLE 202 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 198 TABLE 203 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 198 TABLE 204 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 199 TABLE 205 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 199 TABLE 206 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 200 TABLE 207 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 200 TABLE 208 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 201 TABLE 209 BRAZIL: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 201 TABLE 210 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 202 TABLE 211 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 202 TABLE 212 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 203 TABLE 213 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 204 TABLE 214 MEXICO: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 204 TABLE 215 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 205 TABLE 216 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 205 TABLE 217 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 206 TABLE 218 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 207 TABLE 219 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 207 TABLE 220 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 208 TABLE 221 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 208 TABLE 222 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 209 TABLE 223 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 210 TABLE 224 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 211 TABLE 225 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 211 TABLE 226 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 212 TABLE 227 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 212 TABLE 228 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 213 TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET 214 TABLE 230 URINARY INCONTINENCE DEVICES MARKET: DEGREE OF COMPETITION 217 TABLE 231 URINARY INCONTINENCE DEVICES MARKET: REGION FOOTPRINT 222 TABLE 232 URINARY INCONTINENCE DEVICES MARKET: PRODUCT FOOTPRINT 223 TABLE 233 URINARY INCONTINENCE DEVICES MARKET: PATIENT TYPE FOOTPRINT 224 TABLE 234 URINARY INCONTINENCE DEVICES MARKET: END-USER FOOTPRINT 225 TABLE 235 URINARY INCONTINENCE DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 227 TABLE 236 URINARY INCONTINENCE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 227 TABLE 237 URINARY INCONTINENCE DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 230 TABLE 238 URINARY INCONTINENCE DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025 231 TABLE 239 URINARY INCONTINENCE DEVICES MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 232 TABLE 240 URINARY INCONTINENCE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 232 TABLE 241 COLOPLAST CORP.: COMPANY OVERVIEW 233 TABLE 242 EXCHANGE RATES USED FOR CONVERSION OF DKK TO USD 234 TABLE 243 COLOPLAST CORP.: PRODUCTS OFFERED 235 TABLE 244 COLOPLAST CORP.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 236 TABLE 245 COLOPLAST CORP.: EXPANSIONS, JANUARY 2021–JANUARY 2025 236 TABLE 246 B. BRAUN SE: COMPANY OVERVIEW 238 TABLE 247 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD 239 TABLE 248 B. BRAUN SE: PRODUCTS OFFERED 240 TABLE 249 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 242 TABLE 250 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 243 TABLE 251 CONVATEC INC.: COMPANY OVERVIEW 245 TABLE 252 CONVATEC INC.: PRODUCTS OFFERED 247 TABLE 253 CONVATEC INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 247 TABLE 254 CONVATEC INC.: DEALS, JANUARY 2021– JANUARY 2025 248 TABLE 255 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 249 TABLE 256 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 251 TABLE 257 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021– JANUARY 2025 251 TABLE 258 MEDTRONIC: COMPANY OVERVIEW 253 TABLE 259 MEDTRONIC: PRODUCTS OFFERED 254 TABLE 260 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 255 TABLE 261 TELEFLEX INCORPORATED: COMPANY OVERVIEW 256 TABLE 262 TELEFLEX INCORPORATED: PRODUCTS OFFERED 258 TABLE 263 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 259 TABLE 264 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 260 TABLE 265 CARDINAL HEALTH: COMPANY OVERVIEW 261 TABLE 266 CARDINAL HEALTH: PRODUCTS OFFERED 263 TABLE 267 HOLLISTER INCORPORATED: COMPANY OVERVIEW 264 TABLE 268 HOLLISTER INCORPORATED: PRODUCTS OFFERED 265 TABLE 269 HOLLISTER INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 265 TABLE 270 COOK GROUP: COMPANY OVERVIEW 266 TABLE 271 COOK GROUP: PRODUCTS OFFERED 266 TABLE 272 LABORIE: COMPANY OVERVIEW 267 TABLE 273 LABORIE: PRODUCTS OFFERED 267 TABLE 274 LABORIE: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 268 TABLE 275 WELLSPECT HEALTHCARE: COMPANY OVERVIEW 269 TABLE 276 CALDERA MEDICAL: COMPANY OVERVIEW 270 TABLE 277 DYNAREX CORPORATION: COMPANY OVERVIEW 271 TABLE 278 ADVACARE PHARMA: COMPANY OVERVIEW 272 TABLE 279 MRK HEALTHCARE PVT. LTD.: COMPANY OVERVIEW 273 TABLE 280 ADVIN HEALTH CARE: COMPANY OVERVIEW 274 TABLE 281 CLINIMED LIMITED: COMPANY OVERVIEW 275 TABLE 282 STERIMED GROUP: COMPANY OVERVIEW 276 TABLE 283 KIMBERLEY-CLARK CORPORATION (KCWW): COMPANY OVERVIEW 277 TABLE 284 INCONTROL MEDICAL: COMPANY OVERVIEW 278 TABLE 285 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW 279 TABLE 286 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 280 TABLE 287 STRYKER: COMPANY OVERVIEW 281 _ FIGURE 1 URINARY INCONTINENCE DEVICES MARKET: RESEARCH DESIGN 31 FIGURE 2 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 33 FIGURE 3 URINARY INCONTINENCE DEVICES MARKET: KEY PRIMARY SOURCES 34 FIGURE 4 URINARY INCONTINENCE DEVICES MARKET: KEY INDUSTRY INSIGHTS 36 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37 FIGURE 7 URINARY INCONTINENCE DEVICES MARKET: REVENUE SHARE ANALYSIS 38 FIGURE 8 URINARY INCONTINENCE DEVICES MARKET: US-BASED APPROACH 39 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40 FIGURE 10 URINARY INCONTINENCE DEVICES MARKET: TOP-DOWN APPROACH 41 FIGURE 11 URINARY INCONTINENCE DEVICES MARKET: DATA TRIANGULATION 42 FIGURE 12 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION) 45 FIGURE 13 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2024 VS. 2030 (USD MILLION) 46 FIGURE 14 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION) 46 FIGURE 15 URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 47 FIGURE 16 GEOGRAPHIC SNAPSHOT OF URINARY INCONTINENCE DEVICES MARKET 48 FIGURE 17 RISING PREVALENCE OF URINARY INCONTINENCE TO PROPEL MARKET 49 FIGURE 18 URINARY CATHETERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA IN 2023 50 FIGURE 19 CHINA TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 51 FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 52 FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 53 FIGURE 22 URINARY INCONTINENCE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 FIGURE 23 URINARY INCONTINENCE DEVICES MARKET: VALUE CHAIN ANALYSIS 63 FIGURE 24 URINARY INCONTINENCE DEVICES MARKET: SUPPLY CHAIN ANALYSIS 65 FIGURE 25 URINARY INCONTINENCE DEVICES MARKET: ECOSYSTEM ANALYSIS 65 FIGURE 26 KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET ECOSYSTEM 66 FIGURE 27 URINARY INCONTINENCE DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 68 FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 70 FIGURE 29 KEY BUYING CRITERIA FOR MAJOR END USERS 70 FIGURE 30 PATENT ANALYSIS FOR URINARY INCONTINENCE DEVICES, JANUARY 1, 2015–DECEMBER 31, 2024 78 FIGURE 31 URINARY INCONTINENCE DEVICES MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 32 URINARY INCONTINENCE DEVICES MARKET: INVESTMENT & FUNDING SCENARIO 83 FIGURE 33 EUROPE: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT 157 FIGURE 34 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT 181 FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET (2019–2023) 216 FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET (2023) 217 FIGURE 37 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 220 FIGURE 38 URINARY INCONTINENCE DEVICES MARKET: COMPANY FOOTPRINT 221 FIGURE 39 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 226 FIGURE 40 EV/EBITDA OF KEY VENDORS, 2023–2024 228 FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 228 FIGURE 42 URINARY INCONTINENCE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 229 FIGURE 43 COLOPLAST CORP.: COMPANY SNAPSHOT 234 FIGURE 44 B. BRAUN SE: COMPANY SNAPSHOT 239 FIGURE 45 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 243 FIGURE 46 CONVATEC INC.: COMPANY SNAPSHOT 246 FIGURE 47 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 250 FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT 254 FIGURE 49 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 257 FIGURE 50 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 260 FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT 262

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們